MedTrace Logo

Prediction and Secondary Prevention of Fractures

NCT02608801 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 840

Last updated 2020-03-04

No results posted yet for this study

Summary

The purpose of this study is to investigate patient related factors that contribute to increased risk of recurrent fractures and to investigate patient adherence to prescribed anti-osteoporotic drugs.

Conditions

  • Osteoporotic Fractures
  • Hip Fractures
  • Wrist Fractures
  • Ankle Fractures
  • Vertebral Compression Fractures
  • Humeral Fractures, Proximal

Sponsors & Collaborators

  • Asker & Baerum Hospital

    collaborator OTHER

  • Drammen sykehus

    collaborator OTHER

  • Haukeland University Hospital

    collaborator OTHER

  • Molde Hospital

    collaborator OTHER

  • Norwegian University of Science and Technology

    collaborator OTHER

  • St. Olavs Hospital

    collaborator OTHER

  • University Hospital of North Norway

    collaborator OTHER

  • University of Oslo

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Åshild Bjørnerem, Dr Med · The Arctic University of Norway

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-12-31
Completion
2019-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02608801 on ClinicalTrials.gov